Magnetic resonance imaging and magnetic resonance spectroscopic imaging of prostate cancer

Nature Clinical Practice Urology

Volumn 2, Issue 9, 2005, Pages 434-442

  Huzjan, Renata ^a   Sala, Evis ^b   Hricak, Hedvig ^c,d  

^a University of Zagreb School of Medicine   (Croatia)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

MR spectroscopic imaging; MRI; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER PATIENT; CANCER RECURRENCE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; EVIDENCE BASED MEDICINE; HOSPITAL PERSONNEL; HUMAN; MEDICAL DECISION MAKING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SKILL; TEAMWORK;

HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS;

EID: 27144472777     PISSN: 17434270     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpuro0296     Document Type: Review

References (57)

1. Jemal A et al. (2005) Cancer statistics, 2005. CA Cancer J Clin 55: 10-30
2. Boring CC et al. (1993) Cancer statistics, 1993. CA Cancer J Clin 43: 7-26
3. Amling CL et al. (1998) Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice. Mayo Clin Proc 73: 401-406
4. Stamey TA et al. (1998) Classification of localized untreated prostate cancer based on 791 men treated only with radical prostatectomy: Common ground for therapeutic trials and TNM subgroups. J Urol 159: 2009-2012
5. Kaminski JM et al. (2002) Relationship between prostate volume, prostate-specific antigen nadir, and biochemical control. Int J Radiat Oncol Biol Phys 52: 888-892
6. Zelefsky MJ et al. (2001) High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 166: 876-881
7. Beyersdorff D et al. (2002) Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: Value of MR imaging. Radiology 224: 701-706
8. Yuen JS et al. (2004) Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol 171: 1482-1486
9. Claus FG et al. (2004) Pretreatment Evaluation of Prostate Cancer: Role of MR Imaging and 1H MR Spectroscopy. Radiographics 24 (Suppl 1): S167-S180
10. Hricak H et al. (2003) Advances in imaging in the postoperative patient with a rising prostate-specific antigen level. Semin Oncol 30: 616-634
11. Hricak H et al. (1994) Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal - pelvic phased-array coils. Radiology 193: 703-709
12. Coakley FV and Hricak H (2000) Radiologic anatomy of the prostate gland: a clinical approach. Radiol Clin North Am 38: 15-30
13. Hricak H et al. (1987) MR imaging of the prostate gland: Normal anatomy. AJR Am J Roentgenol 148: 51-58
14. Noguchi M et al. (2000) An analysis of 148 consecutive transition zone cancers: Clinical and histological characteristics. J Urol 163: 1751-1755
15. Perrotti M et al. (1999) Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: A pilot study. J Urol 162: 1314-1317
16. Fleshner NE and Fair WR (1997) Indications for transition zone biopsy in the detection of prostatic carcinoma. J Urol 157: 556-558
17. Liu IJ et al. (2001) Critical evaluation of the current indications for transition zone biopsies. Urology 57: 1117-1120
18. Engelbrecht MR et al. (2003) Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 229: 248-254
19. van Dorsten FA et al. (2004) Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging 20: 279-287
20. Ogura K et al. (2001) Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: Correlation with histopathologic results. Urology 57: 721-726
21. Scheidler J et al. (1999) Prostate cancer: Localization with three-dimensional proton MR spectroscopic imaging - clinicopathologic study. Radiology 213: 473-480
22. 3 spatial resolution. Radiology 198: 795-805
23. Heerschap A et al. (1997) In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue. Anticancer Res 17: 1455-1460
24. Zakian KL et al. (2005) Correlation of proton MR spectroscopic imaging with Gleason score based on step section pathologic analysis after radical prostatectomy. Radiology 234: 804-814
25. Kaji Y et al. (1998) Localizing prostate cancer in the presence of postbiopsy changes on MR images: Role of proton MR spectroscopic imaging. Radiology 206: 785-790
26. Schiebler ML et al. (1993) Current role of MR imaging in the staging of adenocarcinoma of the prostate. Radiology 189: 339-352
27. Heerschap A et al. (1997) Proton MR spectroscopy of the normal human prostate with an endorectal coil and a double spin-echo pulse sequence. Magn Reson Med 37: 204-213
28. Coakley FV et al. (2002) Prostate cancer tumor volume: Measurement with endorectal MR and MR spectroscopic imaging. Radiology 223: 91-97
29. Kurhanewicz J et al. (2000) The prostate: MR imaging and spectroscopy. Present and future. Radiol Clin North Am 38: 115-138, viii-ix
30. Mullerad M et al.: Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol, in press
31. D'Amico AV et al. (2000) Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer. J Urol 164: 759-763
32. Jager GJ et al. (2000) Prostate cancer staging: Should MR imaging be used? - A decision analytic approach. Radiology 215: 445-451
33. Yu KK et al. (1999) Prostate cancer: Prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 213: 481-488
34. Engelbrecht MR et al. (2002) Local staging of prostate cancer using magnetic resonance imaging: A meta-analysis. Eur Radiol 12: 2294-2302
35. Wang L et al. (2004) Prostate cancer: Incremental value of endorectal MR imaging findings for prediction of extracapsular extension. Radiology 232: 133-139
36. Yu KK et al. (1997) Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. Radiology 202: 697-702
37. Mullerad M et al. (2004) Prostate cancer: Detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. Radiology 232: 140-146
38. Hull GW et al. (2002) Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 167: 528-534
39. Catalona WJ et al. (1999) Contemporary results of anatomic radical prostatectomy. CA Cancer J Clin 49: 282-296
40. Bernstein MR et al. (2000) Endorectal coil magnetic resonance imaging and clinicopathologic findings in T1c adenocarcinoma of the prostate. Urol Oncol 5: 104-107
41. Naya Y et al. (2003) Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer. Urology 62: 1058-1062
42. Wymenga LF et al. (2001) Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphatase. BJU Int 88: 226-230
43. Harisinghani MG et al. (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348: 2491-2499
44. Bellin MF et al. (1998) Lymph node metastases: Safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles - initial clinical experience. Radiology 207: 799-808
45. Hovels AM et al. (2004) Cost-analysis of staging methods for lymph nodes in patients with prostate cancer: MRI with a lymph node-specific contrast agent compared to pelvic lymph node dissection or CT. Eur Radiol 14: 1707-1712
46. Daldrup-Link HE et al. (2001) Whole-Body MR Imaging for Detection of Bone Metastases in Children and Young Adults. AJR Am J Roentgenol 177: 229-236
47. Algra PR et al. (1991) Detection of vertebral metastases: comparison between MR imaging and bone scintigraphy. Radiographics 11: 219-232
48. Turner JW et al. (1993) Magnetic resonance imaging for detection of prostate cancer metastatic to bone. J Urol 149: 1482-1484
49. Eustace S et al. (1997) A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol 169: 1655-1661
50. Meijer WG et al. (2003) Bone metastases in carcinoid tumors: clinical features, imaging characteristics, and markers of bone metabolism. J Nucl Med 44: 184-191
51. Traill ZC et al. (1999) Magnetic resonance imaging versus radionuclide scintigraphy in screening for bone metastases. Clin Radiol 54: 448-451
52. Lauenstein TC et al. (2004) Whole-body MR imaging: Evaluation of patients for metastases. Radiology 233: 139-148
53. Lauenstein TC et al. (2002) Three-dimensional volumetric interpolated breath-hold MR imaging for whole-body tumor staging in less than 15 minutes: A feasibility study. AJR Am J Roentgenol 179: 445-449
54. Silverman JM and Krebs TL (1997) MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy. AJR Am J Roentgenol 168: 379-385
55. Sella T et al. (2004) Suspected local recurrence after radical prostatectomy: Endorectal coil MR imaging. Radiology 231: 379-385
56. Nudell DM et al. (2000) Imaging for recurrent prostate cancer. Radiol Clin North Am 38: 213-229
57. Coakley FV et al. (2004) Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: Preliminary experience. Radiology 233: 441-448